- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 20, 2026 | 10.15M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$5.41M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$8.71M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.17M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $4.36M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $20.12M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$881K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$1.3M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $24.5M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $24.15M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.45M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $6.38M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.13M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $7.09M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.04M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.58M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.25M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $5.78M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $7.38 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $6.27 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $7.38 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $6.27 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.61M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.51M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$19.14M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$7.66M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.3M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$7.76M |